STREAMEX CORP. Proceeds from Sale of Equity Method Investments
STREAMEX CORP. (STEX) reported Proceeds from Sale of Equity Method Investments of $25.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfEquityMethodInvestments · last filed 2026-08-14
- STREAMEX CORP. proceeds from sale of equity method investments for the quarter ending 2026-06-30 was $0.00.
- STREAMEX CORP. proceeds from sale of equity method investments for the quarter ending 2026-03-31 was $25.00K.
- STREAMEX CORP. proceeds from sale of equity method investments for the quarter ending 2020-09-30 was -$8.00K.
| Period end | Proceeds from Sale of Equity Method Investments 1 month | Proceeds from Sale of Equity Method Investments 3 month | Proceeds from Sale of Equity Method Investments 6 month | Proceeds from Sale of Equity Method Investments 9 month | Proceeds from Sale of Equity Method Investments 9 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $25.00K 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | $25.00K 10-Q · filed 2026-05-14 | ||||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 | ||||
| 2021-08-11 | $9.10M 10-Q · filed 2021-08-11 | ||||
| 2020-09-30 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $10.59M 10-Q · filed 2021-11-15 | $10.60M 10-Q · filed 2020-11-05 | ||
| 2020-06-30 | $10.60M 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |